Logical model of the cancer report

Definition of the Bundle for reporting to the cancer registry

Definition of the Communication for the date of informing the patient about the cancer registration

Definition of the Composition for reporting to the cancer registry

Definition of the Condition for diseases

Definition of the Condition for the final cause of death

Definition of the DocumentReference for the report as PDF

Definition of the Encounter for the treatment decision

Definition of the Observation for the α-fetoprotein

Definition of the Observation for the Ann Arbor staging

Definition of the Observation for the associated in-situ tumour

Definition of the Observation for the Binet staging

Definition of the Observation for the Breslow thickness

Definition of the Observation for the TNM clinical distant metastases category

Definition of the Observation for the TNM clinical regional nodes category

Definition of the Observation for the COG ALL staging

Definition of the Observation for the COG staging

Definition of the Observation for the TNM clinical primary tumor category

Definition of the Observation for the cerebrovascular accident or transient ischemic attack

Definition of the Observation for the Charlson index

Definition of the Observation for the chronic pulmonary disease

Definition of the Observation for the circumferential resection margins

Definition of the Observation for the clinical tumour size

Definition of the Observation for the congestive heart failure

Definition of the Observation for the connective tissue disease - rheumatic disease

Definition of the Observation for the Creasman grading system

Definition of the Observation for the DSSplus

Definition of the Observation for the date of incidence

Definition of the Observation for the dementia

Definition of the Observation for the diabetes mellitus

Definition of the Observation for the EBV

Definition of the Observation for the Elston/Ellis grading system

Definition of the Observation for the FIGO staging

Definition of the Observation for the Gleason biopsy second most common or highest grade

Definition of the Observation for the Gleason biopsy most common grade

Definition of the Observation for the Gleason excision second most common or highest grade

Definition of the Observation for the Gleason excision most common grade

Definition of the Observation for the Gleason score

Definition of the Observation for the β-hCG

Definition of the Observation for HIV/AIDS

Definition of the Observation for the HPV/p16

Definition of the Observation for the hemiplegia / paraplegia

Definition of the Observation for the Her2 receptor status

Definition of the Observation for the ICCC-3 code

Definition of the Observation for the ICCC-3 extended code

Definition of the Observation for the ICCC-3 main group

Definition of the Observation for the ICD-10 code

Definition of the Observation for the ICD-O-3 behaviour code

Definition of the Observation for the ICD-O-3 histological grade code

Definition of the Observation for the ICD-O-3 laterality code

Definition of the Observation for the ICD-O-3 morphology code

Definition of the Observation for the ICD-O-3 morphology term after transformation

Definition of the Observation for the ICD-O-3 morphology term before change of main diagnosis

Definition of the Observation for the ICD-O-3 topography code

Definition of the Observation for the INRGSS staging

Definition of the Observation for the IRSS staging

Definition of the Observation for the ISS staging

Definition of the Observation for the LDH

Definition of the Observation for the liver disease

Definition of the Observation for the Lugano staging

Definition of the Observation for the lymphatic invasion

Definition of the Observation for the metastases at diagnosis indicator

Definition of the Observation for the microsatellite instability

Definition of the Observation for the moderate to severe chronic kidney disease

Definition of the Observation for the myocardial infarction

Definition of the Observation for the number of examined regional lymph nodes

Definition of the Observation for the number of examined sentinel lymph nodes

Definition of the Observation for the number of involved regional lymph nodes

Definition of the Observation for the number of positive sentinel lymph nodes

Definition of the Observation for the oestrogen receptor status

Definition of the Observation for the TNM pathologic distant metastases category

Definition of the Observation for the TNM pathologic regional nodes category

Definition of the Observation for the PRETEXT staging

Definition of the Observation for the TNM pathologic primary tumor category

Definition of the Observation for the pathological tumour size

Definition of the Observation for the peptic ulcer disease

Definition of the Observation for the perineural invasion

Definition of the Observation for the peripheral vascular disease

Definition of the Observation for the pretreatment prostate specific antigen (PSA)

Definition of the Observation for the progesterone receptor status

Definition of the Observation for the Rai staging

Definition of the Observation for the resection margin in-situ tumour

Definition of the Observation for the resection margin invasive tumour

Definition of the Observation for the residual in-situ tumour

Definition of the Observation for the residual invasive tumour

Definition of the Observation for the Rhabdomyosarcoma site staging

Definition of the Observation for the SIOP staging

Definition of the Observation for the SalzerKuntschik grading system

Definition of the Observation for the sentinel lymph node assessment

Definition of the Observation for the serum tumour markers

Definition of the Observation for the Shimada grading system

Definition of the Observation for the St. Jude / Murphy staging

Definition of the Observation for the TNM stage group

Definition of the Observation for the topography of metastases at diagnosis

Definition of the Observation for the topography of post-diagnosis metastases

Definition of the Observation for the Toronto Tier II (manual) staging

Definition of the Observation for the tumour proliferation labeling

Definition of the Observation for the type of recurrence/transformation

Definition of the Observation for the venous invasion

Definition of the Observation for the WHO(CNS) grading system

Definition of the Observation for the WHO grade group

Definition of the Observation for the a-Prefix of pTNM

Definition of the Observation for the m-Suffix of pT

Definition of the Observation for the y-Prefix of cTNM

Definition of the Observation for the y-Prefix of pTNM

Definition of the Organization of which the organization department forms a part

Definition of the Organization department (hospital) for reporting to the cancer registry

Definition of the Patient for reporting to the cancer registry

Definition of the Practitioner (resident physician) for reporting to the cancer registry

Definition of the Procedure for the diagnostic method(s)

Definition of the Procedure for the method of first detection

Definition of the Procedure for the treatment

Extension to define the function of contact person of an organization

Extension to define the goal for the treatment as part of the first treatment complex

The data item records the serum level of the tumour marker α-fetoprotein (AFP).

This data item is a last modification of the Ann Arbor classification for lymphoma.

This data item records the basis of treatment decision for the entire first treatment complex. The first treatment complex includes all therapy steps planned after the diagnosis.

This data item records the stage of Chronic Lymphocytic Leukaemia (CLL) based on the cell count in the blood and bone marrow (lymphocytes, platelets), haemoglobin/ haematocrit, lymph nodes involvement, hepato- and/or splenomegaly.

COG ALL staging (for childhood B- precursor acute lymphoblastic leukemia, B-ALL) allows a uniform assessment of the extent of CNS involvement based on presence of blasts in the diagnostic cerebrospinal fluid (CSF).

This data item records staging of Wilms’ tumour for pediatric patients acc. to pre-chemotherapy staging system developed by the National Wilms’ Tumor Study Group (NWTSG). Based exclusively on the anatomic extent of the tumour, without consideration of genetic, biologic, or molecular markers.

The circumferential resection margin (CRM) is a surgically created plane produced during the removal of the rectum from its surroundings.

This data item records histopathological grade for uterine or endometrial cancer.

The DSSplus (Durie-Salmon Plus staging system) is the revised Durie-Salmon staging system for multiple myeloma classification, based on MRI findings, FDG PET/CT findings, or both.

The data item records the presence and severity of diabetes mellitus at the time of diagnosis as pre-existing medical condition. Scores weight the estimated effect on patient survival.

The data item records all diagnostic methods used.

This data item records the histopathological grade for breast cancer. It is also called the Nottingham Histological Score. The grade for an individual tumour is derived from an assessment of three morphological features (Tubule formation, Nuclear pleomorphism, Mitotic count), each of which is scored 1-3.

FIGO Staging of gynecologic tumours is based on clinical staging, careful clinical examination before therapy, and surgical exploration.

The data item records the level of serum tumour marker human chorionic gonadotropin (β-hCG).

The data item records the Her2 (human epidermal growth factor receptor 2) expression status of the tumour.

This data item records detailed division of the diagnostic group according to the third revision of the 1996 International Classification of Childhood Cancer (ICCC-3).

This data item records detailed division of the diagnostic group according to the third revision of the 1996 International Classification of Childhood Cancer (ICCC-3).

This data item records the main diagnostic group according to the third revision (2005) of the 1996 International Classification of Childhood Cancer (ICCC-3).

This data item records the paediatric stage classification of the International Neuroblastoma Risk Group Staging System (INRGSS).

The paediatric International Retinoblastoma Staging System is based on extent of disease and the presence of overt extra-ocular extension after enucleation.

The data item records the International Staging System (ISS) for multiple myeloma.

This data item records the behaviour of the neoplasm at time of diagnosis according to ICD-O.

The data item describes the neoplasm’s resemblance to normal (parent) tissue according to ICD-O.

Laterality describes the side of a paired organ or side of the body on which the reportable cancer originated.

The data item records the levels of serum tumour marker lactate dehydrogenase (LDH).

The data item records the presence and severity of liver disease at the time of diagnosis as pre-existing medical condition. Scores weight the estimated effect on patient survival.

The data item is a modification of the Ann Arbor classification for lymphoma.

The data item indicates the presence or absence of tumour cells in lymphatic vessels within and at the margins of the primary tumour, as well as afferent and efferent lymphatics, as noted microscopically by the pathologist.

The data item records the method or circumstance by which the case came to medical attention and the cancer was first diagnosed.

The PRETEXT (PRE-Treatment EXTent of tumor) staging system is used for malignant primary liver tumours of childhood before any therapy. The PRETEXT hepatoblastoma staging is based on Couinaud’s system of segmentation of the liver.

Perineural invasion is the process of neoplastic invasion of nerves.

This classification for Chronic Lymphocytic Leukaemia (CLL) includes 4 stages based on blood and bone marrow cell count (lymphocytes, platelets), haemoglobin/haematocrit, LN envolvement, hepato- and/or splenomegaly. The staging allows classification of patients into three risk categories (low, intermediary, high risk with median survival >12y, >8y and >2y, respectively).

This data items records the in-situ tumour status after treatment. The R classification can be used following surgical treatment alone, after radiotherapy alone, after chemotherapy alone or following multimodal therapy. The status after treatment takes distant metastases into account.

This data items records the invasive tumour status after treatment. The R classification can be used following surgical treatment alone, after radiotherapy alone, after chemotherapy alone or following multimodal therapy. The status after treatment takes distant metastases into account.

Rhabdomyosarcoma staging is based on the classic TNM staging taking into account favourable/non favourable tumour sites. It is used in paediatric oncology.

This data item records staging of Wilms’ tumor for pediatric patients acc. to post-chemotherapy staging system developed by the International Society of Pediatric Oncology (SIOP). Based exclusively on the anatomic extent of the tumor, without consideration of genetic, biologic, or molecular markers.

This data item records the histopathological grade for breast cancer. It is also called the Nottingham Histological Score. The grade for an individual tumour is derived from an assessment of three morphological features (Tubule formation, Nuclear pleomorphism, Mitotic count), each of which is scored 1-3.

The data item indicates whether the sentinel lymph node is excised and the result of the examination. The sentinel lymph node is the first lymph node to receive lymphatic drainage from a primary tumour.

The data item records the TNM S-categories as combination of levels for AFP, hCG, and LDH.

This data item records the grade for neuroblastoma, a frequent childhood cancer. Based on a grade of neuroblastic differentiation and mitosis-karyorrhexis index [MKI]) along with patient age at the time of diagnosis.

The data item records the International Staging System (ISS) for multiple myeloma.

The data item records the UICC TNM stage group.

The data item identifies the distant site(s) of metastatic involvement at time of diagnosis or after disease recurrence.

The Toronto Paediatric Cancer Stage Guidelines recommend the malignancy-specific staging system most suitable for use by population registries for 16 of the most common childhood malignancies. The Guidelines include a two-tiered approach that provides less detailed criteria for registries with limited resources and/or limited data access (Tier 1) based on collapsing of the more detailed criteria (Tier 2).

The goal for each treatment as part of the first treatment complex.

The data item records the type of first recurrence of the disease or the occurrence of a transformation.

The data item indicates the presence or absence of tumour cells in the walls of venous blood vessels, as noted microscopically by the pathologist.

Primary brain tumours are grouped according to the WHO classification based on the cell of origin, and the histological aggressiveness.

A five-grade group system based on the grading categories from Gleason score 2 to 10.

The data item records the absence or presence of distant metastases based on clinical investigation, imaging, endoscopy, surgical exploration without biopsy.

The data item records regional lymph nodes involvement based on clinical investigation, imaging, endoscopy, biopsy or surgical exploration.

The data item records tumour size based on clinical investigation, imaging, endoscopy, biopsy or surgical exploration.

The data item records the unspecified multiplicity of multiple primary tumours at a single site.

The data item records the absence or presence of distant metastasis, based on pathological evidence after completion of surgical therapy or microscopic examination of metastasis.

The data item records the absence or presence and extent of regional lymph node metastasis, based on pathological evidence after completion of surgical therapy.

This data item records the extent of the primary tumour based on pathological (histological) evidence after completion of surgical therapy.

The data item records the serum level of the tumour marker α-fetoprotein (AFP). α-fetoprotein (Variable number: 5.5.1) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This data item is a last modification of the Ann Arbor classification for lymphoma. Ann Arbor staging (Variable number: 4.18) in 'NATIONAL CANCER DATA DICTIONARY, V 1.2, Part A, BASIC VARIABLES for Adults, Adolescents, and Children'

This data item records the basis of treatment decision for the entire first treatment complex. The first treatment complex includes all therapy steps planned after the diagnosis. Basis of first treatment complex decision (Variable number: 7.1) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This data item records the stage of Chronic Lymphocytic Leukaemia (CLL) based on the cell count in the blood and bone marrow (lymphocytes, platelets), haemoglobin/ haematocrit, lymph nodes involvement, hepato- and/or splenomegaly. Binet staging (Variable number: 4.27) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

COG ALL staging (for childhood B- precursor acute lymphoblastic leukemia, B-ALL) allows a uniform assessment of the extent of CNS involvement based on presence of blasts in the diagnostic cerebrospinal fluid (CSF). COG ALL staging (Variable number: 4.20) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This data item records staging of Wilms’ tumour for pediatric patients acc. to pre-chemotherapy staging system developed by the National Wilms’ Tumor Study Group (NWTSG). Based exclusively on the anatomic extent of the tumour, without consideration of genetic, biologic, or molecular markers. COG staging (Variable number: 4.19) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The circumferential resection margin (CRM) is a surgically created plane produced during the removal of the rectum from its surroundings. Circumferential resection margins (Variable number: 5.4.1) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This data item records histopathological grade for uterine or endometrial cancer. Creasman grading system (Variable number: 4.34) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The DSSplus (Durie-Salmon Plus staging system) is the revised Durie-Salmon staging system for multiple myeloma classification, based on MRI findings, FDG PET/CT findings, or both. DSSplus (Variable number: 4.30) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records the presence and severity of diabetes mellitus at the time of diagnosis as pre-existing medical condition. Scores weight the estimated effect on patient survival. Diabetes mellitus (Variable number: 10.1) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part B1, SUPPLEMENTARY VARIABLES for Adults (15.10.2019)' (EN, DE, FR, IT)

The data item records all diagnostic methods used. Diagnostic method(s) used (Variable number: 2.8) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This data item records the histopathological grade for breast cancer. It is also called the Nottingham Histological Score. The grade for an individual tumour is derived from an assessment of three morphological features (Tubule formation, Nuclear pleomorphism, Mitotic count), each of which is scored 1-3. Elston/Ellis grading system (Variable number: 4.35) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

FIGO Staging of gynecologic tumours is based on clinical staging, careful clinical examination before therapy, and surgical exploration. FIGO staging (Variable number: 4.21) in 'NATIONAL CANCER DATA DICTIONARY, V 1.2, Part A, BASIC VARIABLES for Adults, Adolescents, and Children'

The data item records the level of serum tumour marker human chorionic gonadotropin (β-hCG). β-hCG (Variable number: 5.5.2) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records the Her2 (human epidermal growth factor receptor 2) expression status of the tumour. Her2 receptor status (Variable number: 5.1.3) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This data item records detailed division of the diagnostic group according to the third revision of the 1996 International Classification of Childhood Cancer (ICCC-3). ICCC-3 code (Variable number: 3.9.2) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This data item records detailed division of the diagnostic group according to the third revision of the 1996 International Classification of Childhood Cancer (ICCC-3). ICCC-3 code (Variable number: 3.9.3) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This data item records the main diagnostic group according to the third revision (2005) of the 1996 International Classification of Childhood Cancer (ICCC-3). ICCC-3 main group (Variable number: 3.9.1) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This data item records the paediatric stage classification of the International Neuroblastoma Risk Group Staging System (INRGSS). INRGSS staging (Variable number: 4.22) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The paediatric International Retinoblastoma Staging System is based on extent of disease and the presence of overt extra-ocular extension after enucleation. IRSS staging (Variable number: 4.23) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records the International Staging System (ISS) for multiple myeloma. ISS staging (Variable number: 4.29) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This data item records the behaviour of the neoplasm at time of diagnosis according to ICD-O. ICD-O Behaviour (Variable number: 3.6.1) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item describes the neoplasm’s resemblance to normal (parent) tissue according to ICD-O. ICD-O Histological Grade (Variable number: 3.7) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

Laterality describes the side of a paired organ or side of the body on which the reportable cancer originated. Laterality (Variable number: 3.8) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records the levels of serum tumour marker lactate dehydrogenase (LDH). LDH (Variable number: 5.5.3) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records the presence and severity of liver disease at the time of diagnosis as pre-existing medical condition. Scores weight the estimated effect on patient survival. Liver Disease (Variable number: 10.2) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part B1, SUPPLEMENTARY VARIABLES for Adults (15.10.2019)' (EN, DE, FR, IT)

The data item is a modification of the Ann Arbor classification for lymphoma. Lugano staging (Variable number: 4.24) in 'NATIONAL CANCER DATA DICTIONARY, V 1.2, Part A, BASIC VARIABLES for Adults, Adolescents, and Children'

The data item indicates the presence or absence of tumour cells in lymphatic vessels within and at the margins of the primary tumour, as well as afferent and efferent lymphatics, as noted microscopically by the pathologist. Lymphatic invasion (Variable number: 4.14) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records the method or circumstance by which the case came to medical attention and the cancer was first diagnosed. Method of first detection (Variable number: 2.6) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The PRETEXT (PRE-Treatment EXTent of tumor) staging system is used for malignant primary liver tumours of childhood before any therapy. The PRETEXT hepatoblastoma staging is based on Couinaud’s system of segmentation of the liver. PRETEXT staging (Variable number: 4.25) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

Perineural invasion is the process of neoplastic invasion of nerves. Perineural invasion (Variable number: 4.16) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This classification for Chronic Lymphocytic Leukaemia (CLL) includes 4 stages based on blood and bone marrow cell count (lymphocytes, platelets), haemoglobin/haematocrit, LN envolvement, hepato- and/or splenomegaly. The staging allows classification of patients into three risk categories (low, intermediary, high risk with median survival >12y, >8y and >2y, respectively). Rai staging (Variable number: 4.26) in 'NATIONAL CANCER DATA DICTIONARY, V 1.2, Part A, BASIC VARIABLES for Adults, Adolescents, and Children'

This data items records the in-situ tumour status after treatment. The R classification can be used following surgical treatment alone, after radiotherapy alone, after chemotherapy alone or following multimodal therapy. The status after treatment takes distant metastases into account. Residual in-situ tumour (Variable number: 6.2) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This data items records the invasive tumour status after treatment. The R classification can be used following surgical treatment alone, after radiotherapy alone, after chemotherapy alone or following multimodal therapy. The status after treatment takes distant metastases into account. Residual invasive tumour (Variable number: 6.1) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

Rhabdomyosarcoma staging is based on the classic TNM staging taking into account favourable/non favourable tumour sites. It is used in paediatric oncology. Rhabdomyosarcoma site staging (Variable number: 4.28) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This data item records staging of Wilms’ tumor for pediatric patients acc. to post-chemotherapy staging system developed by the International Society of Pediatric Oncology (SIOP). Based exclusively on the anatomic extent of the tumor, without consideration of genetic, biologic, or molecular markers. SIOP staging (Variable number: 4.31) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This data item records the histopathological grade for breast cancer. It is also called the Nottingham Histological Score. The grade for an individual tumour is derived from an assessment of three morphological features (Tubule formation, Nuclear pleomorphism, Mitotic count), each of which is scored 1-3. SalzerKuntschik grading system (Variable number: 4.36) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item indicates whether the sentinel lymph node is excised and the result of the examination. The sentinel lymph node is the first lymph node to receive lymphatic drainage from a primary tumour. Sentinel lymph node assessment (Variable number: 6.5) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records the TNM S-categories as combination of levels for AFP, hCG, and LDH. Serum tumour markers (Variable number: 5.5.4) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This data item records the grade for neuroblastoma, a frequent childhood cancer. Based on a grade of neuroblastic differentiation and mitosis-karyorrhexis index [MKI]) along with patient age at the time of diagnosis. Shimada grading system (Variable number: 4.37) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records the International Staging System (ISS) for multiple myeloma. St. Jude / Murphy staging (Variable number: 4.32) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records the UICC TNM stage group. TNM stage group (Variable number: 4.17) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item identifies the distant site(s) of metastatic involvement at time of diagnosis or after disease recurrence. Sentinel lymph node assessment (Variable number: 6.5) / Topography(s) of post-diagnosis metastases (Variable number: 8.6) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The Toronto Paediatric Cancer Stage Guidelines recommend the malignancy-specific staging system most suitable for use by population registries for 16 of the most common childhood malignancies. The Guidelines include a two-tiered approach that provides less detailed criteria for registries with limited resources and/or limited data access (Tier 1) based on collapsing of the more detailed criteria (Tier 2). Toronto Tier II (manual) staging (Variable number: 4.33.2) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records the type of first recurrence of the disease or the occurrence of a transformation. Type of recurrence(s)/transformation(s) (Variable number: 8.1) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

NKRS codes for data elements for which there is no international code (e.g. LOINC or SNOMED CT) that accurately describes the meaning of the NKRS variable. This code system is based on 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT) and 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part B1, SUPPLEMENTARY VARIABLES for Adults (15.10.2019)' (EN, DE, FR, IT).

The data item indicates the presence or absence of tumour cells in the walls of venous blood vessels, as noted microscopically by the pathologist. Venous invasion (Variable number: 4.15) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

A five-grade group system based on the grading categories from Gleason score 2 to 10. WHO grade group (Variable number: 5.2.7) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records the absence or presence of distant metastases based on clinical investigation, imaging, endoscopy, surgical exploration without biopsy. cM (Variable number: 4.5) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records regional lymph nodes involvement based on clinical investigation, imaging, endoscopy, biopsy or surgical exploration. cN (Variable number: 4.4) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records tumour size based on clinical investigation, imaging, endoscopy, biopsy or surgical exploration. cT (Variable number: 4.3) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records the unspecified multiplicity of multiple primary tumours at a single site. m-Suffix of pT (Variable number: 4.9) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records the absence or presence of distant metastasis, based on pathological evidence after completion of surgical therapy or microscopic examination of metastasis. pM (Variable number: 4.13) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

The data item records the absence or presence and extent of regional lymph node metastasis, based on pathological evidence after completion of surgical therapy. pN (Variable number: 4.10) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

This data item records the extent of the primary tumour based on pathological (histological) evidence after completion of surgical therapy. pT (Variable number: 4.8) in 'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)' (EN, DE, FR, IT)

Example for Organization

Example for Organization

Example for Organization

Example for Organization

Example for Practitioner

Example for Observation for the α-fetoprotein

Example for Observation for the α-fetoprotein

Example for Observation for the α-fetoprotein

Example for Observation for the Ann Arbor staging

Example for Observation for the Ann Arbor staging

Example for Observation for the Ann Arbor staging

Example for Observation for the Ann Arbor staging

Example for Observation for the associated in-situ tumour

Example for Observation for the associated in-situ tumour

Example for Observation for the associated in-situ tumour

Example for Observation for the Binet staging

Example for Observation for the Binet staging

Example for Observation for the Breslow thickness

Example for Observation for the Breslow thickness

Example for Bundle for reporting to the cancer registry

Example for Bundle for reporting to the cancer registry

Example for Bundle for reporting to the cancer registry

Example for Bundle for reporting to the cancer registry

Example for Bundle for reporting to the cancer registry

Example for Bundle for reporting to the cancer registry

Example for Bundle for reporting to the cancer registry

Example for Bundle for reporting to the cancer registry

Example for Bundle for reporting to the cancer registry

Example for Bundle for reporting to the cancer registry

Example for Bundle for reporting to the cancer registry

Example for Bundle for reporting to the cancer registry

Example for Bundle for reporting to the cancer registry

Example for Bundle for reporting to the cancer registry

Example for Observation for the COG ALL staging

Example for Observation for the COG ALL staging

Example for Observation for the COG staging

Example for Observation for the COG staging

Example for Observation for the cerebrovascular accident or transient ischemic attack

Example for Observation for the cerebrovascular accident or transient ischemic attack

Example for Observation for the Charlson index

Example for Observation for the chronic pulmonary disease

Example for Observation for the chronic pulmonary disease

Example for Observation for the circumferential resection margins

Example for Observation for the circumferential resection margins

Example for Observation for the clinical tumour size

Example for Observation for the clinical tumour size

Example for Communication

Example for Communication

Example for Composition

Example for Composition

Example for Composition

Example for Composition

Example for Composition

Example for Composition

Example for Composition

Example for Composition

Example for Composition

Example for Composition

Example for Composition

Example for Composition

Example for Composition

Example for Composition

Example for Condition for the diseases

Example for Condition for the diseases

Example for Observation for the congestive heart failure

Example for Observation for the congestive heart failure

Example for Observation for the connective tissue disease - rheumatic disease

Example for Observation for the connective tissue disease - rheumatic disease

Example for Observation for the Creasman grading system

Example for Observation for the Creasman grading system

Example for Observation for the DSSplus

Example for Observation for the DSSplus

Example for Observation for the date of incidence

Example for Observation for the date of incidence

Example for Observation for the date of incidence

Example for Observation for the dementia

Example for Observation for the dementia

Example for Observation for the diabetes mellitus

Example for Observation for the diabetes mellitus

Example for Observation for the diabetes mellitus

Example for Procedure for the diagnostic method(s)

Example for Procedure for the diagnostic method(s)

Example for Procedure for the diagnostic method(s)

Example for Procedure for the diagnostic method(s)

Example for Procedure for the diagnostic method(s)

Example for Procedure for the diagnostic method(s)

Example for Procedure for the diagnostic method(s)

Example for Procedure for the diagnostic method(s)

Example for Procedure for the diagnostic method(s)

Example for Procedure for the diagnostic method(s)

Example for Procedure for the diagnostic method(s)

Example for DocumentReference for the report as PDF

Example for DocumentReference for the report as PDF

Example for DocumentReference for the report as PDF

Example for DocumentReference for the report as PDF

Example for DocumentReference for the report as PDF

Example for DocumentReference for the report as PDF

Example for DocumentReference for the report as PDF

Example for DocumentReference for the report as PDF

Example for Observation for the EBV

Example for Observation for the EBV

Example for Observation for the EBV

Example for Patient (deceased)

Example for Observation for the Elston/Ellis grading system

Example for Observation for the Elston/Ellis grading system

Example for Practitioner

Example for Observation for the FIGO staging

Example for Observation for the FIGO staging

Example for Observation for the FIGO staging

Example for Condition for the final cause of death

Example for Condition for the final cause of death

Example for Patient

Example for Observation for the Gleason biopsy most common grade

Example for Observation for the Gleason biopsy second most common or highest grade

Example for Observation for the Gleason excision most common grade

Example for Observation for the Gleason excision second most common or highest grade

Example for Observation for the Gleason score

Example for Observation for the Gleason score

Example for Observation for the β-hCG

Example for Observation for the β-hCG

Example for Observation for the β-hCG

Example for Observation for the HIV/AIDS

Example for Observation for the HIV/AIDS

Example for Observation for the HPV/p16

Example for Observation for the HPV/p16

Example for Observation for the HPV/p16

Example for Observation for the hemiplegia / paraplegia

Example for Observation for the hemiplegia / paraplegia

Example for Observation for the Her2 receptor status

Example for Observation for the Her2 receptor status

Example for Observation for the Her2 receptor status

Example for Observation for the ICCC-3 code

Example for Observation for the ICCC-3 extended code

Example for Observation for the ICCC-3 extended code

Example for Observation for the ICCC-3 main group

Example for Observation for the ICD-10 code

Example for Observation for the ICD-10 code

Example for Observation for the ICD-10 code

Example for Observation for the ICD-O-3 behaviour code

Example for Observation for the ICD-O-3 behaviour code

Example for Observation for the ICD-O-3 behaviour code

Example for Observation for the ICD-O-3 histological grade code

Example for Observation for the ICD-O-3 histological grade code

Example for Observation for the ICD-O-3 histological grade code

Example for Observation for the ICD-O-3 laterality code

Example for Observation for the ICD-O-3 laterality code

Example for Observation for the ICD-O-3 laterality code

Example for Observation for the ICD-O-3 morphology code

Example for Observation for the ICD-O-3 morphology code

Example for Observation for the ICD-O-3 morphology code

Example for Observation for the ICD-O-3 topography code

Example for Observation for the ICD-O-3 topography code

Example for Observation for the ICD-O-3 topography code

Example for Observation for the ICD-O-3 morphology term after transformation

Example for Observation for the ICD-O-3 morphology term before change of main diagnosis

Example for Observation for the INRGSS staging

Example for Observation for the INRGSS staging

Example for Observation for the IRSS staging

Example for Observation for the IRSS staging

Example for Observation for the ISS staging

Example for Observation for the ISS staging

Example for Observation for the LDH

Example for Observation for the LDH

Example for Observation for the LDH

Example for Observation for the liver disease

Example for Observation for the liver disease

Example for Observation for the liver disease

Example for Observation for the Lugano staging

Example for Observation for the Lugano staging

Example for Observation for the lymphatic invasion

Example for Observation for the lymphatic invasion

Example for Observation for the lymphatic invasion

Example for Observation for the metastases at diagnosis indicator

Example for Observation for the metastases at diagnosis indicator

Example for Observation for the metastases at diagnosis indicator

Example for Procedure for the method of first detection

Example for Procedure for the method of first detection

Example for Observation for the microsatellite instability

Example for Observation for the microsatellite instability

Example for Observation for the microsatellite instability

Example for Observation for the moderate to severe chronic kidney disease

Example for Observation for the moderate to severe chronic kidney disease

Example for Observation for the myocardial infarction

Example for Observation for the myocardial infarction

Example for Observation for the number of examined regional lymph nodes

Example for Observation for the number of examined regional lymph nodes

Example for Observation for the number of examined regional lymph nodes

Example for Observation for the number of examined regional lymph nodes

Example for Observation for the number of examined sentinel lymph nodes

Example for Observation for the number of examined sentinel lymph nodes

Example for Observation for the number of involved regional lymph nodes

Example for Observation for the number of involved regional lymph nodes

Example for Observation for the number of involved regional lymph nodes

Example for Observation for the number of involved regional lymph nodes

Example for Observation for the number of positive sentinel lymph nodes

Example for Observation for the number of positive sentinel lymph nodes

Example for Observation for the oestrogen receptor status

Example for Observation for the oestrogen receptor status

Example for Observation for the oestrogen receptor status

Example for Observation for the oestrogen receptor status

Example for Observation for the PRETEXT staging

Example for Observation for the PRETEXT staging

Example for Observation for the pathological tumour size

Example for Observation for the pathological tumour size

Example for Observation for the peptic ulcer disease

Example for Observation for the peptic ulcer disease

Example for Observation for the perineural invasion

Example for Observation for the perineural invasion

Example for Observation for the perineural invasion

Example for Observation for the peripheral vascular disease

Example for Observation for the peripheral vascular disease

Example for Observation for the pretreatment prostate specific antigen (PSA)

Example for Observation for the pretreatment prostate specific antigen (PSA)

Example for Condition for the diseases

Example for Observation for the progesterone receptor status

Example for Observation for the progesterone receptor status

Example for Observation for the progesterone receptor status

Example for Observation for the progesterone receptor status

Example for Observation for the Rai staging

Example for Observation for the Rai staging

Example for Observation for the resection margin in-situ tumour

Example for Observation for the resection margin in-situ tumour

Example for Observation for the resection margin in-situ tumour

Example for Observation for the resection margin invasive tumour

Example for Observation for the resection margin invasive tumour

Example for Observation for the resection margin invasive tumour

Example for Observation for the residual in-situ tumour

Example for Observation for the residual in-situ tumour

Example for Observation for the residual invasive tumour

Example for Observation for the residual invasive tumour

Example for Observation for the Rhabdomyosarcoma site staging

Example for Observation for the Rhabdomyosarcoma site staging

Example for Patient

Example for Observation for the SIOP staging

Example for Observation for the SIOP staging

Example for Observation for the SalzerKuntschik grading system

Example for Observation for the SalzerKuntschik grading system

Example for Condition for the diseases

Example for Observation for the sentinel lymph node assessment

Example for Observation for the sentinel lymph node assessment

Example for Observation for the serum tumour markers

Example for Observation for the serum tumour markers

Example for Observation for the serum tumour markers

Example for Observation for the Shimada grading system

Example for Observation for the Shimada grading system

Example for Organization

Example for Organization

Example for Organization

Example for Organization

Example for Observation for the St. Jude / Murphy staging

Example for Observation for the St. Jude / Murphy staging

Example for Observation for the TNM stage group

Example for Observation for the TNM stage group

Example for Observation for the TNM stage group

Example for Observation for the topography of metastases at diagnosis

Example for Observation for the topography of metastases at diagnosis

Example for Observation for the topography of metastases at diagnosis

Example for Observation for the topography of metastases at diagnosis

Example for Observation for the topography of post-diagnosis metastases

Example for Observation for the topography of post-diagnosis metastasess

Example for Observation for the Toronto Tier II (manual) staging

Example for Observation for the Toronto Tier II (manual) staging

Example for Procedure for the treatment

Example for Encounter for the treatment decision

Example for Observation for the tumour proliferation labeling

Example for Observation for the tumour proliferation labeling

Example for Observation for the type of recurrence/transformation

Example for Observation for the type of recurrence/transformation

Example for Observation for the type of recurrence/transformation

Example for Observation for the type of recurrence/transformation

Example for Observation for the type of recurrence/transformation

Example for Observation for the type of recurrence/transformation

Example for Observation for the venous invasion

Example for Observation for the venous invasion

Example for Observation for the venous invasion

Example for Observation for the WHO(CNS) grading system

Example for Observation for the WHO(CNS) grading system

Example for Observation for the WHO grade group

Example for Observation for the WHO grade group

Example for Observation for the a-Prefix of pTNM

Example for Observation for the a-Prefix of pTNM

Example for Observation for the a-Prefix of pTNM

Example for Observation for the TNM clinical distant metastases category

Example for Observation for the TNM clinical distant metastases category

Example for Observation for the TNM clinical distant metastases category

Example for Observation for the TNM clinical regional nodes category

Example for Observation for the TNM clinical regional nodes category

Example for Observation for the TNM clinical regional nodes category

Example for Observation for the TNM clinical primary tumor category

Example for Observation for the TNM clinical primary tumor category

Example for Observation for the TNM clinical primary tumor category

Example for Observation for the m-Suffix of pT

Example for Observation for the m-Suffix of pT

Example for Observation for the m-Suffix of pT

Example for Observation for the m-Suffix of pT

Example for Observation for the m-Suffix of pT

Example for Observation for the TNM pathologic distant metastases category

Example for Observation for the TNM pathologic distant metastases category

Example for Observation for the TNM pathologic distant metastases category

Example for Observation for the TNM pathologic regional nodes category

Example for Observation for the TNM pathologic regional nodes category

Example for Observation for the TNM pathologic regional nodes category

Example for Observation for the TNM pathologic primary tumor category

Example for Observation for the TNM pathologic primary tumor category

Example for Observation for the TNM pathologic primary tumor category

Example for Observation for the y-Prefix of cTNM

Example for Observation for the y-Prefix of cTNM

Example for Observation for the y-Prefix of cTNM

Example for Observation for the y-Prefix of pTNM

Example for Observation for the y-Prefix of pTNM

Example for Observation for the y-Prefix of pTNM